International Conference on Clinical and Applied Microbiology

Important dates

1. 4 Dec

   Abstract / full paper deadline

   In 19 days

2. 31 Dec

   Conference

   Addu, Maldives

All deadlines are as published by the organizer. Check the official website for the time zone.

About this conference

The key intention of ICCAM is to provide opportunity for the global participants to share their ideas and experience in person with their peers expected to join from different parts on the world. In addition this gathering will help the delegates to establish research or business relations as well as to find international linkage for future collaborations in their career path. We hope that ICCAM outcome will lead to significant contributions to the knowledge base in these up-to-date scientific fields in scope.

Topics and scope

• Basic Science
• Pathogenesis
• Animal models including experimental treatment
• Biofilm
• Antimicrobials
• Antimicrobial pharmacokinetics, pharmacodynamics, pharmacogenomics,
• pharmacoeconomics and general pharmacology, drug interaction studies
• Mechanisms of action and resistance
• Resistance surveillance
• Surveys of molecular epidemiology of resistance and resistance genes, strains or serotypes
• In vitro antibacterial susceptibility
• New antimicrobials
• Epidemiology of MRSA, VRE and other Gram-positives
• Epidemiology of MDR-Gram-negatives
• Antibiotic usage
• Molecular biology, including diagnostics
• Molecular bacteriology
• Molecular virology
• Molecular mycology
• Molecular typing
• Molecular biology – others
• Diagnostics, other than Molecular
• Diagnostic/laboratory methods other than molecular
• Methods for antibacterial susceptibility testing
• Public Health
• Public health and community-acquired infections
• Emerging infectious diseases
• Infection Control
• Clinical epidemiology of nosocomial infections
• Travel Medicine, International Health, Tropical Diseases and Parasitology
• Travel medicine, tropical and parasitic diseases
• Mycology
• Resistance and mechanisms of action of antifungals
• Fungal infections
• Virology
• AIDS and HIV infection
• Hepatitis
• Virology non-HIV/non-hepatitis
• Clinical ID
• Mycobacterial infections including diagnosis
• Infection in the immunocompromised host and transplant recipients
• Community-acquired infections including CAP, sepsis, STD, ...
• Lyme borreliosis, toxoplasmosis
• Antimicrobial clinical trials
• Paediatric infections
• Vaccines and Immunology
• Immunology, host defences, immunotherapy
• Vaccines

Call for papers

Abstracts are due by 4 December 2026. Submission details are on the official website.